The ins and outs of injection in Western Australia

QR Code

The ins and outs of injection in Western Australia

Hepatitis C is now the most commonly reported infectious disease in Australia and more than 90% of all infections are the result of injecting drug use. Efforts in Australia to reduce the transmission of this virus among injecting populations have largely been unsuccessful, although there is some evi...

Full description

Bibliographic Details
Main Author:	Carruthers, Susan
Format:	Journal Article
Published:	Informa Healthcare 2003
Subjects:	behaviours injecting drug use risk factors hepatitis C
Online Access:	http://hdl.handle.net/20.500.11937/13407

Similar Items

The Australian Study of HIV and Injecting Drug Use. Part 11: Predicting exposure to hepatitis C and hepatitis B
by: Carruthers, Susan, et al.
Published: (1997)

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)

The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities
by: Loxley, Wendy, et al.
Published: (1997)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)

AIDS and injecting drug use: very risky behaviour in a Perth sample of injecting drug users
by: Loxley, Wendy, et al.
Published: (1994)

"Petunias too, please": further thoughts on achieving control of hepatitis C in Australia
by: Loxley, Wendy
Published: (1997)

Rates of injection in prison in a sample of Australian injecting drug users
by: Fetherston, James, et al.
Published: (2013)

Perceptions of risk and safety within injection settings: Injection drug users' reasons for attending a supervised injecting facility in Vancouver, Canada
by: Small, W., et al.
Published: (2012)

The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships
by: Fraser, Suzanne
Published: (2013)

Doing the possible: harm reduction, injecting drug use and blood borne viral infections in Australia
by: Loxley, Wendy
Published: (2000)

Detection of HCV-specific IFN-gamma responses in HCV antibody and HCV RNA negative injecting drug users
by: Flynn, J., et al.
Published: (2014)

Changes in drug use and HIV/AIDS risk-taking 1989-90
by: Marsh, Alison, et al.
Published: (1995)

HIV risk behaviour among injecting drug users in Perth: the Australian National AIDS and Injecting Drug Use Study
by: Loxley, Wendy, et al.
Published: (1992)

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs
by: Horyniak, Danielle, et al.
Published: (2013)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

DROWNING IN WORDS? USING NUDIST TO ASSIST IN THE ANALYSIS OF LONG INTERVIEW TRANSCRIPTS FROM YOUNG INJECTING DRUG USERS
by: Loxley, Wendy
Published: (2001)

Establishing the Melbourne injecting drug user cohort study (MIX): rationale, methods, and baseline and twelve-month follow-up results
by: Horyniak, D., et al.
Published: (2013)

Age-related differences in patterns of criminal activity among a large sample of polydrug injectors in Australia
by: Horyniak, D., et al.
Published: (2014)

The interface between adaptive and innate neutralisation of virus entry: competition, addition or synergy?
by: Wartnaby, Sophie R.
Published: (2023)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
by: Fraser, S., et al.
Published: (2011)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

A Statistical Experimental Study on Shrinkage of Injection-Molded Part
by: Rajalingam, Sokkalingam, et al.
Published: (2012)

Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: a systematic review
by: Walker, Alex J., et al.
Published: (2018)

The incidence of feline injection site sarcomas in the United Kingdom
by: Dean, Rachel S., et al.
Published: (2013)

Hepatitis B status in migrants and refugees: increasing health burden in Western Australia
by: Subramaniam, K., et al.
Published: (2011)

‘Living a life less ordinary’: exploring the experiences of Australian men who have acquired HIV overseas
by: Brown, G., et al.
Published: (2014)

An evaluation of the opt-out approach to Hepatitis C Virus infection testing in prisons
by: Jack, Kathryn
Published: (2020)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

Experiences of and attitudes towards injecting drug use among marginalised African migrant and refugee youth in Melbourne, Australia
by: Horyniak, D., et al.
Published: (2014)

Availability of HIV prevention and treatment services for people who inject drugs: Findings from 21 countries
by: Petersen, Z., et al.
Published: (2013)

Positive and negative aspects of participation in illicit drug research: Implications for recruitment and ethical conduct
by: Barratt, Monica, et al.
Published: (2007)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
by: Hedegaard, Ditte L., et al.
Published: (2017)

Development and application of the antigen microarray for the detection of autoantibodies in hepatocellular carcinoma patients
by: Afriyie-Asante, Afrakoma
Published: (2019)

Letter to the Editor: The doctor and the clinic: Young peoples' experiences of HIV testing
by: Ovenden, C., et al.
Published: (1994)

Cannot write session to /tmp/vufind_sessions/sess_fqh03jpphlnk0m8kkh1m74djbf